IT1306187B1 - Metodo per l'eradicazione selettiva di cellule tumorali aventi lafunzione di p53 inattiva. - Google Patents

Metodo per l'eradicazione selettiva di cellule tumorali aventi lafunzione di p53 inattiva.

Info

Publication number
IT1306187B1
IT1306187B1 IT1999RM000580A ITRM990580A IT1306187B1 IT 1306187 B1 IT1306187 B1 IT 1306187B1 IT 1999RM000580 A IT1999RM000580 A IT 1999RM000580A IT RM990580 A ITRM990580 A IT RM990580A IT 1306187 B1 IT1306187 B1 IT 1306187B1
Authority
IT
Italy
Prior art keywords
inactive
function
cancer cells
eradication
selective
Prior art date
Application number
IT1999RM000580A
Other languages
English (en)
Inventor
Franco Tato'
Antonio Zanetti
Milena Grossi
Original Assignee
Univ Roma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Roma filed Critical Univ Roma
Publication of ITRM990580A0 publication Critical patent/ITRM990580A0/it
Priority to IT1999RM000580A priority Critical patent/IT1306187B1/it
Priority to EP00964630A priority patent/EP1214397B1/en
Priority to DE60009098T priority patent/DE60009098T2/de
Priority to CA002385424A priority patent/CA2385424A1/en
Priority to AT00964630T priority patent/ATE262033T1/de
Priority to PCT/IT2000/000373 priority patent/WO2001021765A2/en
Priority to ES00964630T priority patent/ES2218224T3/es
Priority to AU75550/00A priority patent/AU7555000A/en
Publication of ITRM990580A1 publication Critical patent/ITRM990580A1/it
Application granted granted Critical
Publication of IT1306187B1 publication Critical patent/IT1306187B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0093—Purging against cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
IT1999RM000580A 1999-09-21 1999-09-21 Metodo per l'eradicazione selettiva di cellule tumorali aventi lafunzione di p53 inattiva. IT1306187B1 (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT1999RM000580A IT1306187B1 (it) 1999-09-21 1999-09-21 Metodo per l'eradicazione selettiva di cellule tumorali aventi lafunzione di p53 inattiva.
AT00964630T ATE262033T1 (de) 1999-09-21 2000-09-21 Methode für die selektive protektion der proliferation der normalen zellen und der selektiven beseitigung der tumorzellen, die eine inaktivierte p53 pathway haben
DE60009098T DE60009098T2 (de) 1999-09-21 2000-09-21 Methode für die selektive protektion der proliferation der normalen zellen und der selektiven beseitigung der tumorzellen, die eine inaktivierte p53 pathway haben
CA002385424A CA2385424A1 (en) 1999-09-21 2000-09-21 Method for the selective protection of proliferating normal cells and the selective eradication of tumor cells having an inactive p53 pathway
EP00964630A EP1214397B1 (en) 1999-09-21 2000-09-21 Method for the selective protection of proliferating normal cells and the selective eradication of tumor cells having an inactive p53 pathway
PCT/IT2000/000373 WO2001021765A2 (en) 1999-09-21 2000-09-21 Method for the selective protection of proliferating normal cells and the selective eradication of tumor cells having an inactive p53 pathway
ES00964630T ES2218224T3 (es) 1999-09-21 2000-09-21 Metodo para la proteccion selectiva de celuls proliferantes normales y erradicacion selectiva de celulas tumorales que tienen una via p53 inactiva.
AU75550/00A AU7555000A (en) 1999-09-21 2000-09-21 Method for the selective protection of proliferating normal cells and the selective eradication of tumor cells having an inactive p53 pathway

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999RM000580A IT1306187B1 (it) 1999-09-21 1999-09-21 Metodo per l'eradicazione selettiva di cellule tumorali aventi lafunzione di p53 inattiva.

Publications (3)

Publication Number Publication Date
ITRM990580A0 ITRM990580A0 (it) 1999-09-21
ITRM990580A1 ITRM990580A1 (it) 2001-03-21
IT1306187B1 true IT1306187B1 (it) 2001-05-30

Family

ID=11406961

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999RM000580A IT1306187B1 (it) 1999-09-21 1999-09-21 Metodo per l'eradicazione selettiva di cellule tumorali aventi lafunzione di p53 inattiva.

Country Status (8)

Country Link
EP (1) EP1214397B1 (it)
AT (1) ATE262033T1 (it)
AU (1) AU7555000A (it)
CA (1) CA2385424A1 (it)
DE (1) DE60009098T2 (it)
ES (1) ES2218224T3 (it)
IT (1) IT1306187B1 (it)
WO (1) WO2001021765A2 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003006060A1 (fr) * 2001-07-09 2003-01-23 Kyowa Hakko Kogyo Co., Ltd. Inhibiteurs de la liaison au domaine sh3

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1969388A (en) * 1987-06-19 1989-01-19 Syracuse University Cytochalasin purification methods and compositions
GB9518536D0 (en) * 1995-09-11 1995-11-08 Pharma Mar Sa Three new cytotoxic macrolides from a marine sponge

Also Published As

Publication number Publication date
AU7555000A (en) 2001-04-24
ITRM990580A0 (it) 1999-09-21
CA2385424A1 (en) 2001-03-29
ES2218224T3 (es) 2004-11-16
WO2001021765A2 (en) 2001-03-29
WO2001021765A3 (en) 2001-10-11
ITRM990580A1 (it) 2001-03-21
EP1214397A2 (en) 2002-06-19
DE60009098T2 (de) 2005-03-24
DE60009098D1 (de) 2004-04-22
EP1214397B1 (en) 2004-03-17
ATE262033T1 (de) 2004-04-15

Similar Documents

Publication Publication Date Title
BR0116452A (pt) Composto, composição farmacêutica, uso de um composto
TR200100366T2 (tr) Aktif madde dağıtmaya mahsus bileşikler ve bileşimler.
DK1093819T3 (da) Forbindelse og præparat til tilförsel af aktive midler
BR9914221B1 (pt) Derivados de glicopeptídeos e composições farmacêuticas contendo os mesmos
NZ506329A (en) Inhibitors of phospholipase enzymes
AR011116A1 (es) Compuesto derivado de n-hidroxi-beta-sulfonil propionamida y composicion farmaceutica que lo contiene
EE03523B1 (et) Fenantridiinid, neid sisaldavad ravimid ja nende kasutamine
AR023777A1 (es) Nuevos compuestos
NO20021859L (no) Nye oligosakkarider, deres fremstilling samt farmasöytiske preparater inneholdende oligosakkaridene
BR0007589A (pt) Inibidores da proliferação de células
PT998460E (pt) Novos derivados de tetrazole
BR9711586A (pt) Compostos e uso dos mesmo
SE9802208D0 (sv) Novel compounds
DE69825626D1 (de) Heterozyklische cytotoxische wirkstoffe
ES2060818T3 (es) Derivados de indol, benzofurano y benzotiofeno sustituidos como inhibidores de la 5-lipooxigenasa.
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
PT1109560E (pt) Compostos uteis como inidores de aicarft
SE9802209D0 (sv) Novel compounds
SE9504662D0 (sv) New compounds
TR200402322T4 (tr) Triptaz inhibitörler
IT1306187B1 (it) Metodo per l'eradicazione selettiva di cellule tumorali aventi lafunzione di p53 inattiva.
PT1244614E (pt) Inibidores de triptase
SE9902742D0 (sv) New pharmaceutical formultion
NO20002321L (no) Bifenylderivater som farmasøytiske midler
ATE217619T1 (de) Endothelin-rezeptor-antagonisten